Mirum acquires Bluejay Therapeutics to expand rare liver disease pipeline
Brelovitug has received breakthrough therapy designation from the US Food and Drug Administration.
Drug Development
FDA to review Eisai’s Leqembi Iqlik sBLA for Alzheimer’s
Daiichi Sankyo and AstraZeneca’s Enhertu gains NMPA approval for HER2 GEJ
Opna Bio’s OPN-2853 secures FDA’s orphan drug status for myelofibrosis
BMS and Microsoft partner for AI-based lung cancer detection
Novo Nordisk and Aspect Biosystems advance partnership for diabetes therapies
iRegene receives FDA RMAT designation for NouvNeu001 to treat Parkinson’s
AstraZeneca to acquire China rights for AbelZeta’s CAR-T therapy
